GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » 5-Year Yield-on-Cost %

Access Bio (XKRX:950130) 5-Year Yield-on-Cost % : 0.00 (As of Dec. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio 5-Year Yield-on-Cost %?

Access Bio's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for Access Bio's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 12 years, Access Bio's highest Yield on Cost was 11.49. The lowest was 0.00. And the median was 9.22.


XKRX:950130's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.96
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Access Bio's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Access Bio's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Access Bio's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Access Bio's 5-Year Yield-on-Cost % falls into.



Access Bio 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Access Bio is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Access Bio  (XKRX:950130) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Access Bio 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Access Bio's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines